Delivery Order SPE2DB20D1100-SPE2DB25FY47A
Award Date
10/9/24
Potential Completion Date
10/31/24
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Envarsus XR 4 mg tablets. The ceiling value of the contract is $2,020.70, and the ultimate completion date is August 6, 2024. This contract is not set aside for any specific business type. AmerisourceBergen Drug Corp's Corporate Office Division will be responsible for fulfilling this delivery...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen). The contract is for the delivery of Envarsus XR 4 mg tablets, with a ceiling value of $3,230.68 and a period of performance through April 11, 2024. This delivery order is issued under an existing $999,999,999.00 indefinite delivery contract between DLA and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Envarsus XR 4 mg tablets. The contract has a ceiling value of $8,076.65 and an ultimate completion date of September 12, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen, as a major pharmaceutical distributor, is leveraging its federal contracting experience and extensive supply chain to deliver this critical medication to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of Envarsus XR 4 mg tablets, a specialty pharmaceutical product, with a ceiling value of $4,845.99 and a period of performance through May 1, 2024. The contract is structured as a firm fixed price delivery order and does not have a set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Envarsus XR 1 mg tablets. The contract has a ceiling value of $1,216.11 and runs through September 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of Envarsus XR 4 mg tablets, a pharmaceutical product, and has a ceiling value of $3,230.68 with a period of performance through August 14, 2024. The contract is a firm-fixed-price type with no set-aside designation. As a major pharmaceutical distributor to the federal government, Amerisourcebergen leverages its extensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Envarsus XR 4 mg tablets, a specialty medication, with a ceiling value of $3,230.68 and a period of performance through October 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Envarsus XR 0.75 mg tablets. The contract has a ceiling value of $2,128.84 and a period of performance ending on September 10, 2024. It is a Firm Fixed Price contract with no set-aside designation. The contract is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of Envarsus XR 1 mg tablets, a medication used for transplant patients. The contract has a ceiling value of $5,307.45 and runs through March 5, 2025. There is no set-aside designation, indicating this was an open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Envarsus XR 4 mg tablets in quantities of 100, with a ceiling value of $1,615.33 and a completion date of July 11, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation. Amerisourcebergen is a major pharmaceutical...